From: Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG
 | DM–/MetS– | DM–/MetS+ | DM+ | Overall |
---|---|---|---|---|
 | n = 375 | n = 279 | n = 256 | p-value |
Female (%) | 15.2 | 26.2 | 23.8 | <0.011,2 |
Mean Age (years) (SD) | 61.3 (8.2) | 60.7 (8.6) | 63.3 (8.4) | <0.0012,3 |
Variables of Modified MetS | ||||
BMI (kg/ m 2 ) | 25.8 | 28.7 | 28.1 | NA |
Elevated Blood Pressure (%) | 40.9 | 83.1 | 67.5 | Â |
HDL Cholesterol (low, %) | 44.9 | 90.2 | 65.3 | Â |
Triglyceride (high, %) | 27.4 | 83.7 | 67.7 | Â |
Elevated Glucose or DM (%) | 4.5 | 25.8 | 100.0 | Â |
Concomitant Diseases | ||||
Hypercholesterolemia (%) | 69.5 | 80.3 | 77.7 | NS |
Previous MI (%) | 70.5 | 67.8 | 67.7 | NS |
Previous TIA or stroke (%) | 8.9 | 8.6 | 13.9 | NS |
Intermittent Claudication (%) | 6.2 | 4.7 | 18.6 | <0.0013,4 |
Renal Function | ||||
CreaCl (ml/min) (SD) | 76.4 (13.8) | 74.2 (18.2) | 73.7 (16.9) | NS |
CreaCl < 60 ml/min/1,73 m 2 (%) | 11.0 | 19.0 | 19.7 | <0.011,2 |
Preoperative Smoking (%) | 66.6 | 60.2 | 66.4 | NS |
Severity of Heart Disease | ||||
EF (%) (SD) | 60 (14) | 61 (13) | 58 (14) | <0.055 |
EF ≤ 35% (%) | 7 | 4 | 11 | <0.055 |
NYHA II (%) | 11.9 | 13.0 | 6.5 | Â |
NYHA III (%) | 59.9 | 54.3 | 56.3 | <0.055 |
NYHA IV (%) | 28.2 | 32.6 | 37.2 | Â |
Operation Characteristics | ||||
Three–vessel Disease (%) | 61.1 | 59.7 | 58.6 | NS |
Left Main Disease (%) | 13.1 | 16.6 | 14.1 | NS |
Number of Grafts | 3.39 | 3.38 | 3.35 | NS |
Use of Arterial Grafts (%) | 86.3 | 83.4 | 81.0 | NS |
Concomitant Operation (%) | 6.1 | 3.3 | 7.6 | NS |
Perfusion Time (SD) | 107.0 (36.6) | 108.0 (58.8) | 112.3 (34.2) | NS |
Urgent or Emergency Operation (%) | 26.7 | 29.9 | 33.5 | NS |